Results 241 to 250 of about 10,264,567 (303)

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Reply to Zoghbi and Innis: Clarifying the cellular basis of GPR84-PET signal in neuroinflammation. [PDF]

open access: yesProc Natl Acad Sci U S A
Kalita M   +5 more
europepmc   +1 more source

Medical device active surveillance of spontaneous reports: A literature review of signal detection methods

Pharmacoepidemiology and Drug Safety, 2020
AbstractPurposeThe collection and analysis of real‐world data for the active monitoring of medical device performance and safety has become increasingly important. Spontaneous reports, such as those in the Food & Drug Administration's (FDA's) Manufacturer and User Facility Device Experience (MAUDE), provide early warning of potential issues with ...
Andrew Yoo, Gary Chung
exaly   +3 more sources

Home - About - Disclaimer - Privacy